![Petter Veiby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petter Veiby
Gründer bei
ATTOVIA THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.08.2026
Profil
Mr. Petter Veiby is a Chief Scientific Officer at Attovia Therapeutics, Inc. He is on the Board of Directors at BiVictriX Therapeutics Plc.
Mr. Veiby was previously employed as a Senior Director by Takeda Oncology Co., a Senior Vice President-Business Development by Immunitas Therapeutics, Inc., a Head-Alliances by Zai Lab Ltd., and a Global Head-Biotherapeutics by Takeda Oncology Co.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.08.2026 | 104’952 ( 0.23% ) | 2 Mio $ | 31.08.2026 |
Aktive Positionen von Petter Veiby
| Unternehmen | Position | Beginn |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Gründer | 16.12.2022 |
| BIVICTRIX THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.08.2025 |
Ehemalige bekannte Positionen von Petter Veiby
| Unternehmen | Position | Ende |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Direktor/Vorstandsmitglied | 01.06.2023 |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Corporate Officer/Principal | 01.11.2022 |
| ZAI LAB LIMITED | Corporate Officer/Principal | 01.05.2022 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.03.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
BiVictriX Therapeutics Plc
 BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Attovia Therapeutics
 Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
